Corcept Therapeutics, Inc. (CORT)
85.86
-21.64
(-20.13%)
USD |
NASDAQ |
Oct 23, 16:00
86.45
+0.59
(+0.69%)
After-Hours: 20:00
Corcept Therapeutics Price : 85.86 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 106.05 | 106.09 | 84.13 | 85.86 | 3.099M |
| Oct 22, 2026 | 115.16 | 115.73 | 107.33 | 107.50 | 809884.0 |
| Oct 21, 2026 | 116.45 | 118.42 | 116.10 | 116.28 | 516766.0 |
| Oct 20, 2026 | 112.60 | 117.14 | 111.96 | 116.45 | 549571.0 |
| Oct 19, 2026 | 111.70 | 113.09 | 110.50 | 112.10 | 392850.0 |
| Oct 16, 2026 | 113.17 | 113.64 | 107.79 | 110.16 | 849971.0 |
| Oct 15, 2026 | 116.31 | 117.48 | 113.02 | 113.37 | 668517.0 |
| Oct 14, 2026 | 117.94 | 122.21 | 115.95 | 116.23 | 691964.0 |
| Oct 13, 2026 | 121.83 | 122.81 | 117.42 | 117.80 | 556292.0 |
| Oct 12, 2026 | 121.24 | 122.09 | 119.28 | 121.19 | 497735.0 |
| Oct 09, 2026 | 118.00 | 122.34 | 117.41 | 121.19 | 624209.0 |
| Oct 08, 2026 | 118.56 | 119.16 | 115.80 | 118.54 | 496666.0 |
| Oct 07, 2026 | 119.00 | 122.00 | 117.23 | 119.60 | 634876.0 |
| Oct 06, 2026 | 122.20 | 122.54 | 115.11 | 119.57 | 790536.0 |
| Oct 05, 2026 | 115.59 | 122.81 | 115.50 | 122.03 | 1.005M |
| Oct 02, 2026 | 114.38 | 117.32 | 113.90 | 116.23 | 960162.0 |
| Oct 01, 2026 | 114.29 | 115.98 | 111.94 | 114.02 | 878988.0 |
| Sep 30, 2026 | 114.80 | 118.07 | 113.98 | 115.23 | 910311.0 |
| Sep 29, 2026 | 115.92 | 120.51 | 113.16 | 114.74 | 964470.0 |
| Sep 28, 2026 | 116.00 | 117.07 | 114.36 | 115.63 | 1.155M |
| Sep 25, 2026 | 119.00 | 120.44 | 114.51 | 116.10 | 800797.0 |
| Sep 24, 2026 | 111.86 | 119.15 | 111.68 | 118.51 | 983632.0 |
| Sep 23, 2026 | 117.33 | 118.79 | 112.04 | 112.94 | 809874.0 |
| Sep 22, 2026 | 113.96 | 119.00 | 113.09 | 117.50 | 810250.0 |
| Sep 21, 2026 | 110.29 | 116.65 | 109.00 | 113.76 | 1.347M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1273.46 |
| Pfizer Inc. | 30.03 |
| Phibro Animal Health Corp. | 38.80 |
| Liquidia Corp. | 42.65 |
| Illumina, Inc. | 269.42 |
Price Related Metrics
| PE Ratio | 205.06 |
| PS Ratio | 11.94 |
| Price to Book Value | 13.13 |
| Price to Free Cash Flow | 92.77 |
| Earnings Yield | 0.49% |
| Market Cap | 9.266B |
| Operating PE Ratio | 1548.68 |
| Normalized PE Ratio | 205.06 |